Prostate Cancer Drugs Market 2021-2026 Forecast and COVID-19 Impact on Business, Industry, Revenue and Actionable Insights

 

The Global Prostate Cancer Drugs Market report provides information by Key Players, Geography, End users, Applications, Competitor analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast.

The report introduces Prostate Cancer Drugs basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis. Insightful predictions for the Prostate Cancer Drugs market for the coming few years have also been included in the report.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand. Cost, price, revenue and gross margins.

Know more https://www.insidemarketreports.com/report/9/791909/Prostate-Cancer-Drugs

Key players in this market are Prostate Cancer Drugs Market 


AbbVie
Novartis
Johnson & Johnson
Astellas Pharma
Merck Group
Astra Zeneca
Bayer HealthCare
GlaxoSmithKline
Sanofi
Amgen
Takeda Pharmaceuticals

Get sample report https://www.insidemarketreports.com/sample-request/9/791909/prostate-cancer-drugs-markets

By Type
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy

By Application
Clinics
Hospitals
Other

Recent Development Of Prostate Cancer Drugs Market 

In June 2021, Novartis' 177Lu-PSMA-617 has been granted as a breakthrough therapy by the US Food and Drug Administration (FDA) for the treatment of metastatic castration-resistant prostate cancer (mCRPC). 177Lu-PSMA-617 is an investigational radioligand therapy that combines a targeting compound and a therapeutic radioisotope. In January 2021, Myovant has partnered with Pfizer to commercialise Orgovyx (relugolix), a prostate cancer drug that will be approved in December 2020. In June 2020, In the United States, Dr. Reddy introduced generic Abiraterone Acetate Tablets USP, 250 mg, a therapeutic equivalent generic version of Zytiga (abiraterone acetate) for prostate cancer.

Comments

Popular posts from this blog

Global Dry Ice Market Analysis 2016-2020 and Forecast 2021-2026

Global Electric Grill Market Segmented By Type (Indoor Grill, Outdoor Grill) By End-user (Residential, Commercial) By Distribution Channel (Online, Offline) & By Region - Forecast And Analysis 2020-2027

Global Synthetic Fuel Market : things you should know